手足症候群の世界市場レポート 2025年

手足症候群の市場規模は、今後数年間で力強い成長が見込まれます。2029年の年間平均成長率（CAGR）は6.9%で、6億7,000万米ドルに成長すると予想されます。予測期間中の成長は、緩和ケアや症状管理ケアの重視の高まり、がんバイオ医薬品の成長、HFS治療の臨床試験の増加、経口治療や在宅治療の需要増加、医療保険適用の世界の増加に起因すると考えられます。この期間に予想される主な動向には、症状管理のための仮想現実（VR）の統合、ウェアラブル健康機器の発展、遺伝子編集と個別化治療のためのCRISPR技術の利用、AIを活用した予測ツールの開発、皮膚状態の理解を深めるための3D画像の応用などがあります。

がんの罹患率の上昇は、手足症候群市場の成長を促進すると予想されます。がんは、体の他の部分に広がる制御不能な細胞増殖を特徴とする状態です。がん患者の増加は、人口の高齢化、ライフスタイルの変化、環境暴露、検出方法の進歩などの要因に影響されています。がん患者の増加に伴い、化学療法の使用量も増加し、化学療法の一般的な副作用である手足症候群の有病率の上昇につながっています。例えば、英国を拠点とする慈善団体Macmillan Cancer Supportは2024年8月、英国では300万人以上ががんと共に生きていると報告しました。この数字は、2025年までに350万人、2030年までに400万人、2040年までに530万人に増加すると予測されています。その結果、がん患者数の増加が手足症候群市場の拡大に寄与すると思われます。

手足症候群市場で事業を展開する企業は、治療の精度と効果を向上させ、患者の予後を改善し、健康な組織へのダメージを最小限に抑えるため、画像誘導放射線治療（IGRT）などの技術革新に注力しています。IGRTは、放射線治療中の正確な腫瘍ターゲティングを確実にするために高度な画像技術を使用し、腫瘍の位置をリアルタイムで追跡・調整できるようにします。例えば、2022年5月、スウェーデンに本拠を置く医療技術企業であるElekta ABは、定位放射線手術の能力を向上させる次世代放射線手術システムであるElekta Espritを発表しました。Elekta Espritは、様々な革新的技術を単一のプラットフォームに統合し、治療チームに優れた可視化とリモートアクセスを提供します。また、柔軟なワークフローをサポートし、シングルセッション、分割、適応、段階的プロトコルに対応し、臨床環境における効率と使いやすさを向上させるよう設計されています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の手足症候群市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の手足症候群市場：成長率分析
• 世界の手足症候群市場の実績：規模と成長、2019～2024年
• 世界の手足症候群市場の予測：規模と成長、2024～2029年、2034年
• 世界の手足症候群総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の手足症候群市場：治療別、実績と予測、2019～2024年、2024～2029年、2034年
• 全身治療
• 局所治療
• 世界の手足症候群市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 腫瘍学
• 皮膚科
• その他
• 世界の手足症候群市場：エンドユーザー別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院
• クリニック
• 在宅ケア設定
• 世界の手足症候群市場：全身治療のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• コルチコステロイド
• 鎮痛剤
• 抗炎症薬
• 世界の手足症候群市場：局所治療のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 尿素ベースクリーム
• コルチコステロイドクリーム
• 保湿剤
• 冷却ジェル

第7章 地域別・国別分析

• 世界の手足症候群市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の手足症候群市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 手足症候群市場：競合情勢
• 手足症候群市場：企業プロファイル
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Bayer AG
• Sanofi S.A.
• Bristol-Myers Squibb Company
• AstraZeneca PLC
• Novartis International AG
• Fresenius Kabi AG
• GlaxoSmithKline plc
• Takeda Pharmaceutical Company Limited
• Eli Lilly and Company
• Gilead Sciences Inc.
• Amgen Inc.
• Regeneron Pharmaceuticals Inc.
• Astellas Pharma Inc.
• UCB Pharma SA
• Eisai Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 手足症候群市場2029：新たな機会を提供する国
• 手足症候群市場2029：新たな機会を提供するセグメント
• 手足症候群市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Hand foot syndrome, also known as palmar-plantar erythrodysesthesia, is a condition triggered by chemotherapy or certain medications. It leads to redness, swelling, pain, and peeling on the palms of the hands and the soles of the feet. In more severe cases, blisters and ulcerations may develop, impacting daily activities.

The primary treatments for hand foot syndrome include both systemic and topical options. Systemic treatments involve medications that work throughout the body to relieve symptoms and prevent complications. These treatments are utilized in various fields such as oncology, dermatology, and others, and are typically administered in hospitals, clinics, and homecare settings.

The hand foot syndrome market research report is one of a series of new reports from The Business Research Company that provides hand foot syndrome market statistics, including the hand foot syndrome industry's global market size, regional shares, competitors with a hand foot syndrome market share, detailed hand foot syndrome market segments, market trends and opportunities, and any further data you may need to thrive in the hand foot syndrome industry. This hand foot syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The hand foot syndrome market size has grown strongly in recent years. It will grow from $0.48 billion in 2024 to $0.52 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth during the historic period can be attributed to the rising prevalence of chronic diseases, an increase in global cancer diagnoses, a growing emphasis on patient-centered cancer care, higher government initiatives and healthcare funding, and a growing focus by pharmaceutical companies on rare and orphan diseases.

The hand foot syndrome market size is expected to see strong growth in the next few years. It will grow to $0.67 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth during the forecast period can be attributed to the increasing emphasis on palliative and symptom management care, growth in oncology biopharmaceuticals, a rise in clinical trials for HFS treatments, increasing demand for oral and at-home treatments, and a global increase in health insurance coverage. Key trends expected in this period include the integration of virtual reality (VR) for symptom management, advancements in wearable health devices, the use of CRISPR technology for gene editing and personalized treatments, the development of AI-powered predictive tools, and the application of 3D imaging for better understanding of skin conditions.

The rising incidence of cancer is expected to drive the growth of the hand-foot syndrome market. Cancer is a condition characterized by uncontrolled cell growth that spreads to other parts of the body. The increasing number of cancer cases is influenced by factors such as aging populations, lifestyle changes, environmental exposures, and advancements in detection methods. As cancer cases rise, chemotherapy usage also increases, leading to a higher prevalence of hand-foot syndrome, which is a common side effect of chemotherapy treatments. For example, in August 2024, Macmillan Cancer Support, a UK-based charity, reported that over 3 million people in the UK were living with cancer. This figure is projected to rise to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the growing number of cancer cases will contribute to the expansion of the hand-foot syndrome market.

Companies operating in the hand-foot syndrome market are focusing on technological innovations such as image-guided radiotherapy (IGRT) to improve the precision and effectiveness of treatments, enhance patient outcomes, and minimize damage to healthy tissues. IGRT uses advanced imaging techniques to ensure accurate tumor targeting during radiation therapy, allowing real-time tracking and adjustment of the tumor's position. For instance, in May 2022, Elekta AB, a Sweden-based medical technology company, introduced the Elekta Esprit, a next-generation radiosurgery system that improves the capabilities of stereotactic radiosurgery. The Elekta Esprit integrates various innovations into a single platform, offering superior visualization and remote accessibility for treatment teams. It also supports flexible workflows, accommodating single-session, fractionated, adaptive, or staged protocols, all designed to improve efficiency and ease of use in clinical environments.

In June 2024, AstraZeneca Plc, a UK-based pharmaceutical company, acquired Fusion Pharmaceuticals Inc. for $2.5 billion. This acquisition aims to strengthen AstraZeneca's oncology portfolio with advanced radiopharmaceuticals, such as FPI-2265, enhance its research and development and manufacturing capabilities, and accelerate the transition to targeted cancer therapies while expanding its presence in Canada. Fusion Pharmaceuticals Inc. is a biotechnology company based in Canada that specializes in developing next-generation radiopharmaceuticals as precision medicines for cancer treatment.

Major players in the hand foot syndrome market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd., Merck & Co. Inc., AbbVie Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, Fresenius Kabi AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., UCB Pharma SA, and Eisai Co. Ltd.

Asia-Pacific was the largest region in the hand food syndrome market in 2024. The regions covered in hand foot syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the hand foot syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hand foot syndrome market consists of revenues earned by entities providing services such as treatments, therapies, and supportive care services for managing symptoms and complications of the condition. The market value includes the value of related goods sold by the service provider or included within the service offering. The hand foot syndrome market also includes sales of pharmaceutical drugs, topical treatments, and medical devices used to alleviate symptoms and manage the condition. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hand Foot Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hand foot syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hand foot syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The hand foot syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Treatment: Systemic Treatment; Topical Treatment
• 2) By Application: Oncology; Dermatology; Other Applications
• 3) By End-User: Hospitals; Clinics; Homecare Settings
• Subsegments:
• 1) By Systemic Treatment: Corticosteroids; Analgesics; Anti-Inflammatory Drugs
• 2) By Topical Treatment: Urea-Based Creams; Corticosteroid Creams; Moisturizers; Cooling Gels
• Companies Mentioned: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; AbbVie Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hand Foot Syndrome Market Characteristics

3. Hand Foot Syndrome Market Trends And Strategies

4. Hand Foot Syndrome Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Hand Foot Syndrome Growth Analysis And Strategic Analysis Framework

• 5.1. Global Hand Foot Syndrome PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Hand Foot Syndrome Market Growth Rate Analysis
• 5.4. Global Hand Foot Syndrome Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Hand Foot Syndrome Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Hand Foot Syndrome Total Addressable Market (TAM)

6. Hand Foot Syndrome Market Segmentation

• 6.1. Global Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Systemic Treatment
• Topical Treatment
• 6.2. Global Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Dermatology
• Other Applications
• 6.3. Global Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Homecare Settings
• 6.4. Global Hand Foot Syndrome Market, Sub-Segmentation Of Systemic Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Corticosteroids
• Analgesics
• Anti-Inflammatory Drugs
• 6.5. Global Hand Foot Syndrome Market, Sub-Segmentation Of Topical Treatment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Urea-Based Creams
• Corticosteroid Creams
• Moisturizers
• Cooling Gels

7. Hand Foot Syndrome Market Regional And Country Analysis

• 7.1. Global Hand Foot Syndrome Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Hand Foot Syndrome Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hand Foot Syndrome Market

• 8.1. Asia-Pacific Hand Foot Syndrome Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hand Foot Syndrome Market

• 9.1. China Hand Foot Syndrome Market Overview
• 9.2. China Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hand Foot Syndrome Market

• 10.1. India Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hand Foot Syndrome Market

• 11.1. Japan Hand Foot Syndrome Market Overview
• 11.2. Japan Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hand Foot Syndrome Market

• 12.1. Australia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hand Foot Syndrome Market

• 13.1. Indonesia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hand Foot Syndrome Market

• 14.1. South Korea Hand Foot Syndrome Market Overview
• 14.2. South Korea Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hand Foot Syndrome Market

• 15.1. Western Europe Hand Foot Syndrome Market Overview
• 15.2. Western Europe Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hand Foot Syndrome Market

• 16.1. UK Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hand Foot Syndrome Market

• 17.1. Germany Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hand Foot Syndrome Market

• 18.1. France Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hand Foot Syndrome Market

• 19.1. Italy Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hand Foot Syndrome Market

• 20.1. Spain Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hand Foot Syndrome Market

• 21.1. Eastern Europe Hand Foot Syndrome Market Overview
• 21.2. Eastern Europe Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hand Foot Syndrome Market

• 22.1. Russia Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hand Foot Syndrome Market

• 23.1. North America Hand Foot Syndrome Market Overview
• 23.2. North America Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hand Foot Syndrome Market

• 24.1. USA Hand Foot Syndrome Market Overview
• 24.2. USA Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hand Foot Syndrome Market

• 25.1. Canada Hand Foot Syndrome Market Overview
• 25.2. Canada Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hand Foot Syndrome Market

• 26.1. South America Hand Foot Syndrome Market Overview
• 26.2. South America Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hand Foot Syndrome Market

• 27.1. Brazil Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hand Foot Syndrome Market

• 28.1. Middle East Hand Foot Syndrome Market Overview
• 28.2. Middle East Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hand Foot Syndrome Market

• 29.1. Africa Hand Foot Syndrome Market Overview
• 29.2. Africa Hand Foot Syndrome Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Hand Foot Syndrome Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Hand Foot Syndrome Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hand Foot Syndrome Market Competitive Landscape And Company Profiles

• 30.1. Hand Foot Syndrome Market Competitive Landscape
• 30.2. Hand Foot Syndrome Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Hand Foot Syndrome Market Other Major And Innovative Companies

• 31.1. Bayer AG
• 31.2. Sanofi S.A.
• 31.3. Bristol-Myers Squibb Company
• 31.4. AstraZeneca PLC
• 31.5. Novartis International AG
• 31.6. Fresenius Kabi AG
• 31.7. GlaxoSmithKline plc
• 31.8. Takeda Pharmaceutical Company Limited
• 31.9. Eli Lilly and Company
• 31.10. Gilead Sciences Inc.
• 31.11. Amgen Inc.
• 31.12. Regeneron Pharmaceuticals Inc.
• 31.13. Astellas Pharma Inc.
• 31.14. UCB Pharma SA
• 31.15. Eisai Co. Ltd.

32. Global Hand Foot Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hand Foot Syndrome Market

34. Recent Developments In The Hand Foot Syndrome Market

35. Hand Foot Syndrome Market High Potential Countries, Segments and Strategies

• 35.1 Hand Foot Syndrome Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Hand Foot Syndrome Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Hand Foot Syndrome Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer